Skip to main navigation Skip to search Skip to main content

Epirubicin/Cisplatin (EC) or EC plus Taxol (TEC) in a two weekly regimenin patients with advanced ovarian carcinoma (AOVCA)

  • J.B Vermorken
  • , K. Hoekman
  • , E.W. Muller
  • , R.V.H.P. Huijskes
  • , C.W. Burger
  • , RHM Verheijen
  • , P. Kenemans
  • , H.M. Pinedo

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 1995
Event5th International Congress on Anti-Cancer Chemotherapy - Paris, France
Duration: 3 Apr 1995 → …

Conference

Conference5th International Congress on Anti-Cancer Chemotherapy
Country/TerritoryFrance
CityParis
Period3/04/95 → …

Cite this